enoxaparin becat 20mg/0.2ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin becat 40mg/0.4ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin becat 60mg/0.6ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin becat 80mg/0.8ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin becat 100mg/1ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
arixtra- fondaparinux sodium injection, solution
physicians total care, inc. - fondaparinux sodium (unii: x0q6n9usoz) (fondaparinux - unii:j177fow5jl) - fondaparinux sodium 5 mg in 0.4 ml - arixtra® is indicated for the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe): - in patients undergoing hip fracture surgery, including extended prophylaxis; - in patients undergoing hip replacement surgery; - in patients undergoing knee replacement surgery; - in patients undergoing abdominal surgery who are at risk for thromboembolic complications. arixtra is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium. arixtra is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital. arixtra is contraindicated in the following conditions: - severe renal impairment (creatinine clearance [crcl] <30 ml/min). [see warnings and precautions (5.2) and use in specific populations (8.6).] - active major bleeding. - bacterial endocarditis. - thrombocytopenia associated with a positive in vitro test for anti-platelet antib
fondaparinux sodium injection, solution
italfarmaco s.p.a - fondaparinux sodium (unii: x0q6n9usoz) (fondaparinux - unii:j177fow5jl) - fondaparinux sodium injection is indicated for the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe): - in patients undergoing hip fracture surgery, including extended prophylaxis; - in patients undergoing hip replacement surgery; - in patients undergoing knee replacement surgery; - in patients undergoing abdominal surgery who are at risk for thromboembolic complications. fondaparinux sodium injection is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium. fondaparinux sodium injection is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital. fondaparinux sodium injection is contraindicated in the following conditions:(4) - severe renal impairment (creatinine clearance [crcl] <30 ml/min). [see warnings and precautions (5.3) and use in specific populations (8.6).] - active major bleeding. - bacterial endocardi
fondaparinux sodium injection, solution
zydus pharmaceuticals (usa) inc. - fondaparinux sodium (unii: x0q6n9usoz) (fondaparinux - unii:j177fow5jl) - fondaparinux sodium injection is indicated for the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe): - in patients undergoing hip fracture surgery, including extended prophylaxis; - in patients undergoing hip replacement surgery; - in patients undergoing knee replacement surgery; - in patients undergoing abdominal surgery who are at risk for thromboembolic complications. fondaparinux sodium injection is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium. fondaparinux sodium injection is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital. fondaparinux sodium injection is contraindicated in the following conditions:(4) - severe renal impairment (creatinine clearance [crcl] <30 ml/min). [see warnings and precautions (5.3) and use in specific populations (8.6).] - active major bleeding. - bacterial endocardi
enoxaparina 100mg/ml sandoz solución inyectable en jeringa precargada i.v., s.c.
sandoz gmbh - enoxaparina sÓdica - enoxaparina sÓdica....100 mg.
lovenox forte enoxaparin sodium 150mg/1ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium -